MXPA99003665A - Aminophenol derivatives and their use in cosmetics - Google Patents
Aminophenol derivatives and their use in cosmeticsInfo
- Publication number
- MXPA99003665A MXPA99003665A MXPA/A/1999/003665A MX9903665A MXPA99003665A MX PA99003665 A MXPA99003665 A MX PA99003665A MX 9903665 A MX9903665 A MX 9903665A MX PA99003665 A MXPA99003665 A MX PA99003665A
- Authority
- MX
- Mexico
- Prior art keywords
- radical
- aminophenol
- hydrogen atom
- carbon atoms
- branched
- Prior art date
Links
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 239000002537 cosmetic Substances 0.000 title claims description 14
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 210000004209 hair Anatomy 0.000 claims abstract description 38
- 238000004061 bleaching Methods 0.000 claims abstract description 7
- 239000007844 bleaching agent Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000007854 depigmenting agent Substances 0.000 claims abstract description 3
- 210000003491 skin Anatomy 0.000 claims description 30
- 125000004432 carbon atom Chemical group C* 0.000 claims description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- 229920006395 saturated elastomer Polymers 0.000 claims description 16
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000008099 melanin synthesis Effects 0.000 claims description 4
- BECNKUVYBNETOM-UHFFFAOYSA-N ethyl n-(4-hydroxyphenyl)carbamate Chemical compound CCOC(=O)NC1=CC=C(O)C=C1 BECNKUVYBNETOM-UHFFFAOYSA-N 0.000 claims description 3
- SLPPBRLLAWJEIM-UHFFFAOYSA-N 1-ethyl-3-(4-hydroxyphenyl)urea Chemical compound CCNC(=O)NC1=CC=C(O)C=C1 SLPPBRLLAWJEIM-UHFFFAOYSA-N 0.000 claims description 2
- 229940124091 Keratolytic Drugs 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- NDMNOCFEDLHFKY-UHFFFAOYSA-N ethyl 5-(ethoxycarbonyloxyamino)-2-hydroxybenzoate Chemical compound C(C)OC(=O)ONC1=CC(=C(C=C1)O)C(=O)OCC NDMNOCFEDLHFKY-UHFFFAOYSA-N 0.000 claims description 2
- 230000001530 keratinolytic effect Effects 0.000 claims description 2
- 239000003410 keratolytic agent Substances 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 101710147108 Tyrosinase inhibitor Proteins 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 16
- -1 alkoxy radical Chemical class 0.000 description 29
- 150000003254 radicals Chemical group 0.000 description 23
- 239000000047 product Substances 0.000 description 13
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 8
- 230000035614 depigmentation Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000003061 melanogenesis Effects 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 210000002752 melanocyte Anatomy 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 208000000069 hyperpigmentation Diseases 0.000 description 4
- 230000003810 hyperpigmentation Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 229960004705 kojic acid Drugs 0.000 description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000007957 coemulsifier Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 231100001231 less toxic Toxicity 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002088 nanocapsule Substances 0.000 description 2
- 239000002077 nanosphere Substances 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229940032067 peg-20 stearate Drugs 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LKVFCSWBKOVHAH-UHFFFAOYSA-N 4-Ethoxyphenol Chemical compound CCOC1=CC=C(O)C=C1 LKVFCSWBKOVHAH-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- NPVMUYGQDFCCHX-QRPNPIFTSA-N OC1=CC=CC=C1.ON(O)[C@H](C(O)=O)CC1=CC=CC=C1 Chemical compound OC1=CC=CC=C1.ON(O)[C@H](C(O)=O)CC1=CC=CC=C1 NPVMUYGQDFCCHX-QRPNPIFTSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Chemical class 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- QNEPTKZEXBPDLF-JDTILAPWSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] carbonochloridate Chemical compound C1C=C2C[C@@H](OC(Cl)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QNEPTKZEXBPDLF-JDTILAPWSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003901 ceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DEQYTNZJHKPYEZ-UHFFFAOYSA-N ethyl acetate;heptane Chemical compound CCOC(C)=O.CCCCCCC DEQYTNZJHKPYEZ-UHFFFAOYSA-N 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 125000002819 montanyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJJWJAFSUDWTTR-UHFFFAOYSA-N n,n-dihydroxyaniline Chemical compound ON(O)C1=CC=CC=C1 FJJWJAFSUDWTTR-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Abstract
The invention concerns novel aminophenol derivatives, a composition containing them and their use in a composition as depigmenting and/or bleaching agent for human skin, hairs and/or hair. The invention also concerns a method for depigmenting and/or bleaching the skin, hairs and/or hair, which consists in applying on human skin, hairs and/or hair a composition containing said novel compounds (I).
Description
COMPOUNDS DERIVED FROM AMXNOPHENOL AND ITS USE IN COSMETICS
DESCRIPTION OF THE INVENTION The present invention relates to the use of aminophenol derivatives, as depigmentation agent or bleaching agent in a cosmetic and / or dermatological composition, to a cosmetic and / or dermatological composition comprising said derivatives and to new derivatives of aminophenol. The color of human skin varies depending on different factors and especially the seasons, race and sex, and is determined mainly by the nature and concentration of melanin produced by elanocytes. Melanocytes are specialized cells that, through particular organelles, melanosomes, synthesize melanin. On the other hand, in different periods of life, some people see appearing on the skin and more precisely on the hands, darker and / or more colored spots, which give the skin a heterogeneous appearance. These spots are also due to a significant concentration of melanin in the keratinocytes that are found on the surface of the skin. REF .: 29830 In the same way, the color of the hairs and the hair is due to the melanin, when the hairs or the hair are dark, some people want them to look lighter. This is particularly interesting for those hairs that are less visible when they are clear, than when they are dark. The mechanism of formation of the pigmentation of the skin, of the hairs and hairs, that is to say of the formation of melanin, is particularly complex and intervenes in it schematically, the following main stages:
Tyrosine - > Dopa - > Dopaquinone - Dopacrom - > Melanin
Tyrosine (monophenol dihydroxylphenylalanine: oxygenated reductase EC 1.14.18.1) is the essential enzyme involved in this sequence of reactions. It catalyzes especially the reaction of transformation of tyrosine in Dopa (dihydroxyphenylamine) thanks to its hydroxylase activity and the reaction of Dopa transformation in dopaquinone, thanks to its oxidase activity. This tyrosinase only acts when it is in a state of maturation, under the action of some biological factors.
It is understood that a substance is depigmenting, if it acts directly on the vitality of the epidermal melanocytes where the elanogenesis develops and / or if one of the stages of the biosynthesis of melanin interferes, either by inhibiting one of the enzymes involved in melanogenesis , or interspersed as a structural analogue of one of the chemical compounds of the melanin synthesis chain, a chain that can then be blocked and thus ensure depigmentation. The substances most commonly used as depigmentation agents are more precisely hydroquinone and its derivatives, in particular its ethers, such as monomethyl ether and hydroquinone monoethyl ether. Although these compounds have a certain effectiveness, unfortunately, they are not exempt from side effects due to their toxicity, which makes their use delicate, and even dangerous. This toxicity is due to the fact that they intervene in fundamental mechanisms of melanogenesis, killing cells that can then disturb their biological environment and therefore force the skin, to evacuate them producing toxins. In this way, hydroquinone is a particularly irritating and cytotoxic compound for melanocytes, whose total or partial replacement has been addressed by numerous authors. For this reason, substances that do not intervene in the mechanism of melanogenesis have been sought, but they act earlier on tyrosinase, preventing their activation and that is why they are much less toxic. Kojic acid, which forms a heterocycle with the copper present in the active site of this enzyme. Unfortunately, this compound can cause allergic reactions ("Contact allergy to kojic acid in skin care products") Nakagawa M. et al., in Contact Dermatitis, Jan. 95, Vol 42 (1), pp. 9-13). That compound is also unstable in solution, which complicates the manufacture of the composition a little. The use of harmless topical depigmenting substances, which present an important efficacy, is being investigated, with a view to treating regional hyperpigmentation by melanocytic hyperpigmentation, such as idiopathic melasmas, resulting from pregnancy ("pregnancy mask" or chloasma) or of estroprogestogenic contraception, hyperpigmentations localized by hyperactivity and benign melanocytic proliferation, such as senile pigmentary spots called actinic lentigo, hyperpigmentation or accidental depigmentation, possibly due to photosensitization or scarring after an injury, as well as certain leukodermias , such as vitiligo. For the latter, (the scarring can end in a scar that gives the skin a whiter appearance and leucodermias), as it can not repigment the injured skin, the areas of normal residual skin are depigmented, to give the skin in its set, a homogeneous white hue. Also, there remains a need for a new bleaching agent for human skin, hair and / or hair action as effective as known, but does not present its drawbacks, ie it is non-irritating, non-toxic and / or non-allergic to the skin and stable in a composition. The applicant has unexpectedly found that the new aminophenol derivatives exhibit a depigmenting activity, even at low concentrations, without showing signs of toxicity. The subject of the present invention is therefore to provide the following aminophenol derivatives of formula (I):
wherein: R represents a hydrogen atom or a radical -C0R, with R ', identical or different, representing a radical chosen from an alkyl or alkoxy radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 optionally hydroxylated carbon atoms, Ri is selected from a radical of formulas (a), (b) or (c) below: (a) -CO-NR3R4 (b) -CO-O-R5 (c) -SOc-Rs with R representing a hydrogen atom or an alkyl radical with 1 to 6 carbon atoms, linear or branched, saturated or unsaturated, optionally hydroxylated, with R 4 representing a hydrogen atom or a radical chosen from an alkyl, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms, optionally hydroxylated, with R 5 representing a hydrogen atom chosen from an alkyl, saturated or unsaturated, linear, cyclic or branched radical, with 1 to 30 carbon atoms , optionally hydroxylated, in a depigm cosmetic composition and / or bleach of human skin, hair or hair. These compounds have the advantage of being easy to obtain. They can be obtained in particular by reacting an aminophenol with an activated chemical entity, such as an imidazolide or an isocyanate, when R is a radical of formula (a), a chloroformate, when R is a radical of formula (b), or a chloride of sulfonyl, when Ri is a radical of formula (c). According to the present invention, linear or branched alkyl radicals having from 1 to 30 carbon atoms may advantageously be mentioned as methyl, ethyl, propyl, isopropyl, butyl, tertbutyl, hexyl, octyl, nonyl, 2- radicals. ethylhexyl and dodecyl. Preferably, these radicals have from 1 to 12 carbon atoms. Even more preferably, the alkyl radical generally comprises from 1 to 6 carbon atoms. Mention may be made, as the lower alkyl radical, of methyl, ethyl, propyl, isopropyl, tertbutyl, hexyl radicals.
Among the linear alkyl radicals having from 1 to 30 carbon atoms, mention may be made especially of the methyl, ethyl, propyl, octyl, dodecyl, tridecyl, hexadecyl, behenyl, octadecyl, tetracosyl, hexacosyl, octacosyl and myristyl radicals. Among the branched alkyl radicals having from 1 to 30 carbon atoms, mention may be made especially of the 2-ethylhexyl, 2-butyloctyl, 2-hexyldecyl radicals. When unsaturated, a radical having one or more ethylenic unsaturations is preferred, such as, more precisely, the radical neryl, 2-nonyl-2-butenyl, 6 (1,3-pentadienyl) -2,4,7-dodecanetrien-9- inil and more particularly, the allyl radical. When the alkyl radical is cyclic, the cyclohexyl, cholesteryl or tert-butylcyclohexyl radical can be mentioned in particular. When it is hydroxylated, the radical preferably comprises 1 to 6 carbon atoms and 1 to 5 hydroxyl groups. Among the monohydroxyalkyl radicals, a radical containing preferably 1 or 3 carbon atoms, in particular the hydroxyethyl, 2-hydroxyethyl, 2 or 3-hydroxypropyl radicals, is preferred.
Among the polyhydroxyalkyl radicals,
• prefers a radical having from 3 to 6 carbon atoms and from 2 to 5 hydroxyl groups, such as 2, 3-dihydroxypropyl, 2, 3, 4-trihydroxbutyl, 2, 3, 4, 5-tetrahydroxypentyl radicals and , 3,4,5,6-pentahydroxyhexyl. Alkoxylated radicals are alkyl radicals, such as in particular those described above, preceded by an oxygen atom. Preferably, the aminophenol derivatives of the present invention are those for which at least one and preferably all the following conditions are respected: - R represents a hydrogen atom, - the -OR function on the phenyl radical is in position ortho or advantageously in position for,
Ri is chosen from a radical of formulas (a) or (b). The compounds of formula (I) are chosen more precisely, between N-ethyloxycarbonyl-4-aminophenol, N-ethyloxycarbonyl-O-ethyloxycarbonyl-4-aminophenol; he
N-Chloesteryloxycarbonyl-4-aminophenol and the
N-ethyl-aminocarbonyl-4-aminophenol. The present invention also relates to compositions comprising at least one aminophenol derivative of formula (I) and a cosmetically and / or dermatologically acceptable medium. This composition is intended more precisely for a topical use on the skin and / or its phallic areas (hair, hairs and nails). This cosmetic or dermatological composition is advantageously intended to depigment and / or bleach the human skin and / or remove the pigmented spots on the skin and / or depigment the hairs and / or the hairs. The subject of the present invention is also the use of these aminophenol derivatives in and / or for the manufacture of a cosmetic and / or dermatological composition, as an inhibitor of tyrosinase and / or of the synthesis of melanin and / or as an agent of depigmentation and / or bleaching of the skin, of the hairs or of the hair. Another subject of the present invention is new aminophenol derivatives of the following formula (I):
wherein: R represents a hydrogen atom or a radical -COR2, with R2,. which represents a radical chosen from an alkyl or alkoxy radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms optionally hydroxylated, Ri is selected from the following radicals: (a) -CO-NR3R4 (b) a choleseryloxycarbonyl radical (c) -SO2-R5 with R3 representing a hydrogen atom or an alkyl radical with 1 to 6 carbon atoms, linear or branched, saturated or unsaturated, optionally hydroxylated, with R4 representing a hydrogen atom or a radical chosen from an alkyl radical, saturated or unsaturated, linear, cyclic or branched, with 13 to 30 carbon atoms, optionally hydroxylated, with R 5 representing a hydrogen atom chosen from an alkyl, saturated or unsaturated, linear, cyclic radical or branched, with 1 to 30 carbon atoms, optionally hydroxylated. The present invention also relates to a cosmetic depigmentation and / or bleaching process of human skin, hair or hair consisting of applying to the skin, hairs or hair a cosmetic composition according to the invention. The composition according to the invention is suitable for topical use and therefore contains a cosmetically or dermatologically acceptable medium, that is to say compatible with the skin, the hair or the hair. The aminophenol derivatives will be used in an effective amount to obtain the desired depigmentation or bleaching effect and this amount will be present depending on the nature of the aminophenol derivatives considered. Particularly, the aminophenol derivatives of formula (I) can be present in the composition, especially in an amount ranging from 0.001 to 10% and preferably from 0.005 to 5% of the total weight of the composition. The composition of the invention can be present in all galenic forms normally used for a topical application, especially in the form of an aqueous, hydroalcoholic or oily solution, of an oil-in-water or water-in-oil or multiple emulsion, of a gel aqueous or oily, from a liquid, pasty or solid anhydrous product, from a dispersion of oil in an aqueous phase with the help of spherules, these spherules being able to be polymeric nanoparticles such as nanospheres and nanocapsules or better still, lipid vesicles of the type ionic or non-ionic. This composition can be more or less fluid and have the appearance of a white or colored cream, an ointment, a milk, a lotion, a serum, a paste, a foam. It can eventually be applied on the skin or on the hair in the form of an aerosol. It can also be presented in solid form, and for example in the form of a bar. It can be used as a care product and / or as a makeup product. It can also be presented in the form of shampoo or after shampooing. In a known way, the composition of the invention can also contain the usual additives used in the fields of cosmetics and dermatology, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, perfumes, fillers, filters, pigments , odor absorbents and coloring matters. The amounts of these different additives are those conventionally used in the areas considered, and for example from 0.01 to 20% of the total weight of the composition. These additives, according to their nature, can be introduced in the fatty phase, in the aqueous phase, in the lipid vesicles and / or in the nanoparticles. When the composition of the invention is an emulsion, the proportion of the fatty phase can range from 5 to 80% by weight, and preferably from 5 to 50% by weight with respect to the total weight of the composition. The oils, emulsifiers and co-emulsifiers used in the composition in the form of an emulsion are chosen from those conventionally used in the field in question. The emulsifier and the coemulsifier are present in the composition, in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight with respect to the total weight of the composition. As oils capable of being used in the invention, mineral oils (petroleum jelly), oils of vegetable origin (avocado oil, soybean oil), oils of animal origin can be mentioned.
(lanolin), synthetic oils (perhydrosqualene), silicone oils (cyclomethicone) and fluorinated oils (perfluoropolyethers). It can also be used as fats of fatty alcohols
(cetyl alcohol), fatty acids, waxes (carnauba wax, ozokerite).
As emulsifiers and co-emulsifiers which can be used in the invention, mention may be made, for example, of the fatty acid and polyethylene glycol esters such as PEG-20 stearate, and the fatty acid and glycerin esters such as glyceryl stearate. As hydrophilic gelling agents, mention may be made, in particular, of the carboxyvinyl polymers
(carbomer), acrylic copolymers such as acrylate / alkyl acrylate copolymers, polyacrylamides, polysaccharides, natural gums and clays, and, as lipophilic gelling agents, there may be mentioned modified clays such as benthones, metal salts of acids fatty acids, hydrophobic silica and polyethylenes. As active, polyols (glycerin, propylene glycol), vitamins, keratolytic and / or scavenging agents (salicylic acid and its derivatives, alpha-hydroxy acids, ascorbic acid and its derivatives), anti-inflammatory agents, soothing agents can be used or its mixtures. It is also possible to associate the aminophenol derivatives with other depigmentation agents, such as kojic acid or hydroquinone and its derivatives, which allows the latter to be used in doses less toxic to the skin. In case of incompatibility, these assets and / or the aminophenol derivatives can be incorporated into spherules, especially ionic or non-ionic vesicles and / or nanoparticles (nanocapsules and / or nanospheres), so as to isolate them from each other in the composition. Next, the invention will be illustrated with the help of the following examples. The concentrations are given in percentage of weight.
Examples of compounds
EXAMPLE 1 N-Ethyloxycarbonyl-4-aminophenol 20 g of 4-aminophenol (Mw = 109.13, 0.18324 mol) are suspended in 200 cm 3 of anhydrous dichloromethane under an inert atmosphere. Cool to a temperature of 0 ° C in an ice bath, then add 16.4 cm3 of anhydrous pyridine (Mw = 79.10, d = 0.981, 0.2034 mol). Then, dropwise, so as to maintain at a temperature lower than 10 ° C, 17.6 cm 3 of ethyl chloroformate (Mw = 108.53, d = 1.13, 0.18324 mol) is added. The reaction mixture is kept under stirring for two hours. The mixture is poured into one liter of ice water, then extracted with ethyl acetate. The organic phase is washed with water, then dried, filtered and evaporated in vacuo. After recrystallization from a heptane-ethyl acetate mixture, a white powder of mass 21 g is obtained, which corresponds to a yield of 63%. The melting temperature of the product obtained is 127.2 ° C. The 1 H NMR spectrum and the elemental analysis are in accordance with the expected product.
EXAMPLE 2 N-Ethyloxycarbonyl-O-ethyloxycarbonyl-1-4-aminophenol 10 g of 4-aminophenol (Mw = 109.13, 0.0916 mol) in 100 cm 3 of anhydrous dichloromethane are suspended in an inert atmosphere. Cool to a temperature of 0 ° C in an ice bath, then add 8.2 cm3 of anhydrous pyridine (Mw = 79.10, d = 0.981, 0.102 mol). Then, dropwise, so as to maintain at a temperature lower than 10 ° C, 9.8 cm3 of ethyl chloroformate (Mw = 108.53, d = 1.13, 0.104 mol) is added. The reaction mixture is kept under stirring for two hours. The mixture is poured into one liter of ice water, then extracted with ethyl acetate. The organic phase is washed with water, then dried, filtered and evaporated in vacuo. After recrystallization from ethanol, a white powder of mass 18 g is obtained, which corresponds to a yield of 80%. The melting temperature of the product obtained is 110.8 ° C. The 1H 200MHz NMR spectrum and the elemental analysis are in accordance with the expected product.
Example 3 N-cholesteryloxycarbonyl-4-aminophenol 21.8 g of 4-aminophenol (Mw = 109.13) are suspended.; 0.2 mol) in 200 cm3 of anhydrous N, N-dimethylacetamide, under an inert atmosphere. Then, dropwise, so as to maintain at a temperature lower than 30 ° C, 44.9 cm3 of cholesteryl chloroformate (Mw = 449.11, 0.1 mol) is added. The mixture is kept reacting under stirring for two hours. The mixture is poured into five liters of water, then filtered and the precipitate is dried. After recrystallization from a water-ethanol mixture, a white powder with a mass of 46 g is obtained, which corresponds to a yield of 88%. The melting temperature of the product obtained is 186.9 ° C. The 13C lOOMHz NMR spectrum and the elemental analysis are in accordance with the expected product.
Example 4 N-Ethylaminocarbonyl-1-aminophenol 10 g of 4-aminophenol are suspended.
(Mw = 109.13; 0.0916 mol) in 100 cm3 of anhydrous N-methylpyrrolidone, under inert atmosphere. Then, 6.5 g of ethyl isocyanate (Mw = 71.08, 0.0914 mol) are added dropwise. The reaction mixture is brought to a temperature of 60 ° C under stirring for two hours. The mixture is poured into one liter of water, then filtered and the precipitate is dried. After recrystallization from ethanol, a white powder of mass 9 g is obtained, which corresponds to a yield of
55%. The melting temperature of the product obtained is 173. ° C. The 1H 200MHz NMR spectrum and the elemental analysis are in accordance with the expected product.
Tests: A biological test has demonstrated the depigmenting activity of the aminophenol derivatives of formula (I). This test corresponds to that described in patent FR 2734825 filed by the applicant, as well as in the article by R. Schmidt, P. Krine and M. Régnier, Anal. Bioche., 235 (2), 113-18, (1996). This test was carried out on a coculture of keratinocytes and melanocytes.
For each compound tested, the IC50 value corresponding to the micromolar concentration (μM) has been determined for which 50% inhibition of melanogenesis is observed. On the other hand, a class has been assigned to each of these compounds for its maximum depigmenting activity: Class 1: 10 to 30% inhibition of melanogenesis with respect to the control (same experience without the compound to be tested); Class 2: 30 to 60% inhibition of melanogenesis with respect to the control (same experience without the compound to be tested); Class 3: 60 to 100% inhibition of melanogenesis with respect to the control (same experience without compound to be tested). The results are gathered in the following table (1) •
These compounds of formula (1) therefore have a greater depigmenting efficacy than kojic acid. In addition, they have the advantage of not presenting cytotoxicity against keratinocytes and melanocytes, which is the major defect of the existing depigmenting agents.
Examples of compositions Example 5: Treatment cream - Cetyl alcohol 1. 05%
- PEG-20 stearate (Myrj 49 sold by the company ICI) 2%
- Cyclomethicone 6%
- Compound of example 1 0. 5%
- Carbomer 0 6%
- Glycerin 3%
- Triethanolamine 1%
- Preservatives 0.5%
- Demineralized water qsp 100% The cream obtained used in daily application, allows to obtain a bleaching of the skin.
Example 6: Treatment Gel - Propylene Glycol 10%
- Ethyl alcohol 40% - Glycerin 3%
- Compound of example 2 0.5%
- Preservatives 0.15%
- Perfume 0.15%
- Demineralised water qsp 100% The gel obtained can be used daily and is suitable for depigmenting the skin.
Example 7: Treatment bar - Carnauba wax 5% - Ozokerite 7% - Lanolin 6% - Titanium dioxide (pigments) 20% - Rice starch (charge) 7% - EDTA 0.1%
- Compound of example 3 2% - Perhydrosqualene qsp 100% The obtained bar, used on the pigmented spots, allows to attenuate them even to make them disappear. It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is the conventional one for the manufacture of the objects or products to which it refers.
Claims (10)
-
- . Having described the invention as above, the content of the following claims is claimed as property: 1. Use of at least one aminophenol derivative of the following formula (I): characterized in that: R represents a hydrogen atom or a radical -COR2, with R¿, representing a radical chosen from an alkyl or alkoxyl radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms optionally hydroxylated Ri is selected from a radical of formulas (a), (b) or (c) below: (a) -CO-NR3R4 (b) -co-o-Rs (c) -S0.-Ro with R representing a hydrogen atom or an alkyl radical with 1 to 6 carbon atoms, linear or branched, saturated or unsaturated, optionally hydroxylated, with R 4 representing a hydrogen atom or a radical chosen from an alkyl radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms, optionally hydroxylated, with R 5 representing a hydrogen atom chosen from an alkyl, saturated or unsaturated, linear, cyclic or branched radical, with 1 to 30 carbon atoms, optionally hydroxylated, in a depigmenting cosmetic composition and / or bleaching of human skin, hair or hair. 2. Use according to claim 1, characterized in that said aminophenol derivative has at least one and preferably all of the following conditions: R represents a hydrogen atom, - The -OR function on the phenyl radical is ortho or advantageously in para position, Ri is chosen from a radical of formulas (a) or (b).
- 3. Derivatives according to claim 1 6 2, characterized in that they are chosen from N-ethyloxycarbonyl-4-aminophenol; N-ethyloxycarbonyl-O-ethyloxycarbonyl-4-aminophenol; N-cholesteryloxycarbonyl-4-aminophenol and N-ethylaminocarbonyl-4-aminophenol.
- 4. Use of at least one derivative having the formula (I), characterized in that it has been defined in any of claims 1 to 3, in and / or for the manufacture of a cosmetic and / or dermatological composition, as a tyrosinase inhibitor and / o of the synthesis of melanin.
- 5. Cosmetic and / or dermatological composition characterized in that it comprises at least one aminophenol derivative of formula (I) as defined in any of claims 1 to 4 and a cosmetically and / or dermatologically acceptable medium. Composition according to the preceding claim, characterized in that it is intended to depigment and / or bleach the human skin and / or remove the pigmented spots on the skin and / or depigment the hairs and / or the hairs. Composition according to any one of claims 5 to 6, characterized in that the aminophenol derivative is present in an amount ranging from 0.001 to 10% and preferably from 0.005 to 5% of the total weight of the composition. 8. Composition according to any of claims 5 to 7, characterized in that the composition also comprises at least one active selected from the keratolytic and / or scavenging agents, anti-inflammatory, painkillers, other depigmenting agents and mixtures thereof. 9. Aminophenol derivatives of the following formula (I): characterized in that: R represents a hydrogen atom or a radical -COR2, with R2 / representing a radical chosen from an alkyl or alkoxyl radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms optionally hydroxylated, Ri is selected from the following radicals: (e) a choleseriloxycarbonyl radical (f) -S02-R5 with R3 representing a hydrogen atom or an alkyl radical with 1 to 6 carbon atoms, linear or branched, saturated or unsaturated, optionally hydroxylated, with R 4 representing a hydrogen atom or a radical chosen from an alkyl radical, saturated or unsaturated, linear, cyclic or branched, with 13 to 30 carbon atoms, optionally hydroxylated, with R 5 representing a hydrogen atom chosen from an alkyl radical, saturated or unsaturated, linear, cyclic or branched, with 1 to 30 carbon atoms, optionally hydroxylated. Cosmetic procedure for depigmenting and / or bleaching of human skin, hair or hair, characterized in that it consists in applying to the skin, hair or hair a composition described according to any of the preceding claims 5 a 8
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR97/10710 | 1997-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA99003665A true MXPA99003665A (en) | 2000-01-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6924275B2 (en) | Aminophenol derivatives and their use in cosmetics | |
| US6365135B1 (en) | Use of amino phenol amide derivatives as depigmentation agents | |
| US6306376B1 (en) | Use of arbutin monoesters as depigmenting agents | |
| US6159482A (en) | Use of oxamate derivatives as depigmenting agents | |
| JP3558653B2 (en) | Composition for topical application to skin and / or surface growth thereof, comprising at least one compound having an iminophenol fragment | |
| JP3139843B2 (en) | A skin or cosmetic composition having a decolorizing effect, comprising a (2,5-dihydroxyphenyl) carboxylic acid derivative, a homolog or a salt thereof as an active ingredient. | |
| JP2000119127A (en) | Cosmetic and / or dermatological composition comprising at least one mulberry extract, at least one skullcap extract and at least one salicylic acid derivative | |
| FR2751535A1 (en) | USE OF MELATONIN DERIVATIVES FOR SKIN DEPIGMENTATION AND COMPOSITIONS COMPRISING THE SAME | |
| JP2001039828A (en) | Topical cosmetic composition comprising benzaldoxime | |
| JP3001834B2 (en) | Depigmenting agent comprising N, N'-dibenzylethylenediamine-N, N'-diacetate derivative | |
| US6228350B1 (en) | Method of depigmenting and/or bleaching skin and/or body hair or head hair | |
| JP2873219B2 (en) | Composition containing octopirox as depigmenting agent and use thereof | |
| MXPA99003665A (en) | Aminophenol derivatives and their use in cosmetics | |
| US6960347B2 (en) | Composition based on N-cholesteryloxycarbonyl-4-para-aminophenol and hydroquinone or one of its derivatives |